Literature DB >> 21377889

Trans-catheter closure of the native aortic valve with an Amplatzer Occluder to treat progressive aortic regurgitation after implantation of a left-ventricular assist device.

Jochen Grohmann1, Philipp Blanke, Christoph Benk, Christian Schlensak.   

Abstract

We report on a patient with ischaemic dilated cardiomyopathy, who developed progressive regurgitation of his native aortic valve after implantation of a left-ventricular assist device (LVAD, HeartMate II). Increasing regurgitant volume led to reduced effective cardiac output and worsening of symptoms. To overcome aortic regurgitation, we successfully closed his aortic valve minimally invasively using the Amplatzer(®) P.I. Muscular VSD Occluder. This led to instant haemodynamic stabilisation. We observed significant residual regurgitation through the Occluder during the initial phase, which led temporarily to increased haemolysis and subsequently to worsening of kidney function; once the haemolysis ceased, we noted a very good interventional and clinical result at short-term follow-up.
Copyright © 2011 European Association for Cardio-Thoracic Surgery. Published by Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21377889     DOI: 10.1016/j.ejcts.2011.01.036

Source DB:  PubMed          Journal:  Eur J Cardiothorac Surg        ISSN: 1010-7940            Impact factor:   4.191


  8 in total

Review 1.  Simultaneous procedures during left ventricular assist device implantation: is less always more?

Authors:  Nikhil Jaik; Robert S D Higgins; Bryan A Whitson
Journal:  Curr Heart Fail Rep       Date:  2014-03

Review 2.  Management of aortic insufficiency in the continuous flow left ventricular assist device population.

Authors:  Jonathan Holtz; Jeffrey Teuteberg
Journal:  Curr Heart Fail Rep       Date:  2014-03

Review 3.  Impact of adverse events on ventricular assist device outcomes.

Authors:  Aleksandar Adzic; Snehal R Patel; Simon Maybaum
Journal:  Curr Heart Fail Rep       Date:  2013-03

4.  Central aortic valve closure successfully treated aortic insufficiency of the patient with Jarvik 2000 continuous flow left ventricular assist device: a case report.

Authors:  Yoshifumi Itoda; Kan Nawata; Haruo Yamauchi; Osamu Kinoshita; Mitsutoshi Kimura; Minoru Ono
Journal:  J Artif Organs       Date:  2016-10-15       Impact factor: 1.731

5.  Medical management of patients with continuous-flow left ventricular assist devices.

Authors:  Adam D Devore; Robert J Mentz; Chetan B Patel
Journal:  Curr Treat Options Cardiovasc Med       Date:  2014-02

Review 6.  Percutaneous Transcatheter Therapies for the Management of Left Ventricular Assist Device Complications.

Authors:  Rohan J Kalathiya; Jonathan Grinstein; Nir Uriel; Atman P Shah
Journal:  J Invasive Cardiol       Date:  2017-02-15       Impact factor: 2.022

7.  Unusual complications following left ventricular assisted device implantation: case series.

Authors:  Amjad Shalabi; Erez Kachel; Yigal Kassif; Muin Faqeeh; Preisman Sergey; Leonid Sternik; Liza Grosman-Rimon; Wadi Kinany; Offer Amir; Eylon Ram; Jacob Lavee; Avishay Grupper
Journal:  J Cardiothorac Surg       Date:  2021-04-06       Impact factor: 1.637

8.  HFA of the ESC position paper on the management of LVAD-supported patients for the non-LVAD specialist healthcare provider Part 3: at the hospital and discharge.

Authors:  Finn Gustafsson; Binyamin Ben Avraham; Ovidiu Chioncel; Tal Hasin; Avishai Grupper; Aviv Shaul; Sanemn Nalbantgil; Yoav Hammer; Wilfried Mullens; Laurens F Tops; Jeremy Elliston; Steven Tsui; Davor Milicic; Johann Altenberger; Miriam Abuhazira; Stephan Winnik; Jacob Lavee; Massimo Francesco Piepoli; Lorrena Hill; Righab Hamdan; Arjang Ruhparwar; Stefan Anker; Marisa Generosa Crespo-Leiro; Andrew J S Coats; Gerasimos Filippatos; Marco Metra; Giuseppe Rosano; Petar Seferovic; Frank Ruschitzka; Stamatis Adamopoulos; Yaron Barac; Nicolaas De Jonge; Maria Frigerio; Eva Goncalvesova; Israel Gotsman; Osnat Itzhaki Ben Zadok; Piotr Ponikowski; Luciano Potena; Arsen Ristic; Tiny Jaarsma; Tuvia Ben Gal
Journal:  ESC Heart Fail       Date:  2021-09-28
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.